Events

With recent accelerated approval wins, positive clinical trial readouts, progression through clinical pipelines and exciting mergers and acquisitions, it has certainly been an industry-defining year for the rare and genetic renal space. In the context of rapid progress and a mounting desire to propel game-changing novel therapies that will add to the arsenal of therapeutic options for patients, the 4th Rare and Genetic Kidney Disease Drug Development Summit returns to Boston. This unique event for the industry, academic KOL, and patient advocacy nephrology community provides an unrivalled opportunity to discuss acceleration of clinical advancements in orphan kidney disease populations. This year's meeting brings together 30+ expert speakers, a two-tracked pre-conference workshop day and ne…

As biopharmaceutical pipelines expand with increasingly complex modalities at a faster rate than ever, the landscape for EHS leaders is rapidly evolving. Navigating the complexities of compliance regulations while safeguarding your workforce has never been more critical. With an increasing number of R and D and manufacturing facilities across large pharma, biotech, CDMOs, and CROs, handling potentially hazardous chemical and biological materials, the demand for robust biosafety, ergonomic, chemical, and environmental protocols is at an all-time high.  You'll have the unique chance to network with a focused group of EHS leaders from Genentech, Eli Lilly, Takeda and more as they share high-level strategies and practical, day-to-day solutions. You'll be in the company of over 60 global d…

Achieving Efficacy and Exploring Indication Expansion for Complement Inhibitors The complement community is shifting gear, with more companies than ever targeting alternative complement proteins for their therapies, allowing for a larger range of diseases to be targeted. With more assets in ophthalmology, neurology, and oncology than ever before, the complement-based therapeutics field has everyone asking the same question: which inhibitor will be the next to harness the complement system for the development of groundbreaking therapies? From the discovery of new pathways to target to post-approval indication expansion, the immunology landscape is primed to capitalize on the huge strides being taken in achieving efficacy and approving the safety profile of complement-based therapeutics. Joi…

With Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering with Depixus, there has been many valuable collaborations entering the RNA-targeting field accelerating efficacious and selective small molecules targeting RNA directly, RNA-binding proteins and RNA/protein complexes. Hence, as the go-to meeting for the RNA-targeting small molecule the community, the 7th Annual RNA-Targeted Drug Discovery and Development Summit returns to Boston this December. Increase your knowledge of RNA tertiary structures, delve into innovative preclinical modelling strategies and identify optimal chemical features for advancing specific, efficacious and safe small molecules. Unite with 100+ RNA Science, Medicinal Chemistry, Structural Biology and Biophysics experts from the likes of Astra…

Uniting Large Pharma, Innovative Biotech and Leading Academics to Eliminate the Boundaries of Druggability with Novel Covalent Drugs With continued advancements in screening platforms and proteomics, the covalency renaissance continues as biopharma race to unlock hard-to-target proteins across oncology, immunology and CNS. We are witnessing this industry make great strides in utilizing novel covalent modalities and elucidating novel warheads to target amino acids beyond cysteine. However, developing covalent drugs remains no easy feat, as knowledge gaps persist in balancing reactivity and selectivity, de-risking the ligandability of alternative residues, and tackling PKPD disconnects and efficiency bottlenecks to successfully develop potent covalent drugs for unmet clinical need. The 2nd C…

One of the most pivotal gatherings of your industry peers is happening soon and now's the time to get ahead of your competitors. CPHI Middle East is set to transform Riyadh, Saudi Arabia, into an epicentre of pharmaceutical business, innovation, and high-impact networking from 10-12 December 2024. More than just an industry event; CPHI ME is set to be a game-changer and here's why:- Tap Into The Fastest-Growing Market: With the Saudi Arabian pharmaceutical market soaring to a staggering USD 12.1 billion in 2023, there's no better time to expand your horizons. At CPHI Middle East, you'll connect with leading healthcare providers from across the region, unlock new avenues in the biggest market, and position your brand at the forefront of this lucrative landscape.- Unparalleled Networking: Wi…

With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it's time to make the most of evolving process analytical technology (PAT) to design robust and cost-effective control strategies to understand more about your biopharmaceutical products. Recent blockbusters like GLP-1 peptides have sparked unprecedented investment into advanced manufacturing strategies, such as Novo Nordisk's recent $11B acquisition to expand manufacturing capacity. The maturity of PAT tools and the development of sophisticated software and chemometrics now provide the perfect opportunity to revolutionize traditional quality and analytical approaches, achieving the digital manufacturing maturity necessary for the future. Join over 100 leading PAT scientists, engineers, proce…

A comprehensive ICRS Focus Meeting will address those questions, offer some answers, and help doctors, physiotherapists, sports scientists, a.o. to get better in cartilage repair and regeneration. Although much focus has been placed in recent years on the efficacy and efficiency of various techniques for treating cartilage damage in the knee joint, the indication and selection of patients is the most important parameter in cartilage regenerative therapy. This ICRS Focus Meeting focuses on clinical, imaging, and scientific aspects of this vital field and takes a look into the future to improve cartilage regenerative therapies further by knowing and influencing prognostic factors. Date and Time: Thursday, 12 December 2024 at 13:00 to Saturday, 14 December 2024 at 15:00

Scripps' Structural Heart Intervention and Imaging conference is designed to provide a practical, cutting-edge, and live case-based assessment of structural heart disease interventions and cardiovascular imaging. The course will place a strong emphasis on the collaborative nature of these procedures across many disciplines within cardiology. Expert faculty will include interventionists, invasive cardiologists, echocardiologists, electrophysiologists, cardiothoracic surgeons, cardiac anesthesiologists, and sonographers. Faculty will discuss clinical guidelines on patient selection, pre-procedural assessment, procedural tips, techniques, and challenges (including concurrent imaging) during the performance of the procedures and conclude with assessment of outcomes and future directions.  …

Critical Issues America2025 Annual Conference - February 7-8, 2025The meeting will help participants to identify and manage complications associated with endovascular and open repair of complex aortic disease including: arch descending thoracic, TAAA, pararenal and juxtarenal aneurysms, aortoiliac aneurysms and other miscellaneous pathologies affecting the aorta. CIA will recognize potential treatment failure and the role of advance imaging techniques in the evaluation, treatment, and management of aortic disease. The target audience includes physicians who specialize in vascular surgery, cardiology, interventional radiology, vascular medicine, cardiothoracic surgery, as well as fellows, and allied health professionals. Objectives:Provide an overview of current and unmet management of DLE…

Embark on a transformative journey at the prestigious 8th Edition of the International Conference on Materials Science and Engineering, poised to take place in the enchanting city of Rome, Italy, and virtually from March 10 - 12, 2025, themed "Materials for Tomorrow: Advancements in Materials Science & Engineering" Esteemed scholars, researchers, academics, industry mavens, and enthusiasts from around the world are warmly invited to engage in this dynamic symposium, fostering interdisciplinary collaboration and the exchange of insights. Venture into the expansive realm of materials science and engineering, where innovation knows no bounds. Explore a diverse array of materials, from cutting-edge polymers to revolutionary biomaterials, each offering unique applications across various sec…

Our Pharma Supply Chain & Security World Conference & expo to be held on the 11 & 12 March 2025 is back in London, United Kingdom for the 6th time. Focusing on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharma Supply Chain & Security World 2025 - Supply-Chain, Anti-Counterfeiting, Drug Serialization and Packaging & Labeling conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partners…

Our Pharma Supply Chain & Security World Conference & expo to be held on the 11 & 12 March 2025 is back in London, United Kingdom for the 6th time. Focusing on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharma Supply Chain & Security World 2025 - Supply-Chain, Anti-Counterfeiting, Drug Serialization and Packaging & Labeling conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partners…

Our Pharma Supply Chain & Security World Conference & expo to be held on the 11 & 12 March 2025 is back in London, United Kingdom for the 6th time. Focusing on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharma Supply Chain & Security World 2025 - Supply-Chain, Anti-Counterfeiting, Drug Serialization and Packaging & Labeling conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partners…

Jacob Javits Convention Center, 429 11th Avenue, New York, New York, 10001, United States

INTERPHEX provides direct access to the tools and resources to accelerate your drug-to-market journey efficiently and effectively. INTERPHEX bridges the gap between science and business by uniting industry professionals across the entire pharmaceutical product development lifecycle. Engage with leading experts during scientifically vetted education sessions, discover live demonstrations of machinery and equipment from a diverse offering of exhibitors, and forge valuable connections at INTERPHEX. Who attends INTERPHEX? From scientists and researchers, to processing and manufacturing engineers, INTERPHEX convenes the entire pharmaceutical product development lifecycle like no other event. Business types include manufacturing and production, packing and distribution, contract manufacturing an…

The i-Cancer Congress is a premier international event scheduled to take place in Toronto, Canada on May 26-27, 2025. This congress brings together leading experts, researchers, healthcare professionals, and industry leaders in the field of oncology to discuss and share the latest advancements in cancer research, treatment, and care. The i-Cancer Congress offers an unparalleled opportunity to stay updated on the latest trends and developments in oncology. Attendees will benefit from educational sessions, networking opportunities, and exposure to innovative solutions and technologies shaping the future of cancer treatment. This event is designed to enhance knowledge, foster collaboration, and inspire new approaches to combat cancer. Event Highlights Cutting-Edge Research Presentations: Eng…